LB Pharmaceuticals Ownership | Who Owns LB Pharmaceuticals?
LB Pharmaceuticals Ownership Summary
LB Pharmaceuticals is owned by 113.15% institutional investors, 0.24% insiders. Deep track capital, lp is the largest institutional shareholder, holding 11.87% of LBRX shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 2.47% of its assets in LB Pharmaceuticals shares.
LBRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | LB Pharmaceuticals | 113.15% | 0.24% | -13.39% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Deep track capital, lp | 3.35M | 11.87% | $108.82M |
| Ra capital management | 2.21M | 7.82% | $71.68M |
| Blackrock funding, inc. /de | 2.35M | 7.79% | $90.07M |
| Commodore capital lp | 1.50M | 5.31% | $48.68M |
| Tcg crossover management | 1.45M | 5.12% | $46.97M |
| Caligan partners lp | 1.44M | 5.09% | $46.67M |
| Jpmorgan chase | 1.44M | 4.79% | $53.84M |
| Spruce street capital lp | 1.40M | 4.66% | $53.86M |
| Vanguard group | 1.11M | 4.40% | $24.77M |
| Fmr | 1.10M | 3.66% | $39.54M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nan fung group | 630.66K | 16.17% | $24.20M |
| Spruce street capital lp | 1.40M | 8.56% | $53.86M |
| Vivo capital | 800.00K | 3.38% | $30.70M |
| Commodore capital lp | 1.50M | 2.90% | $48.68M |
| Caligan partners lp | 1.44M | 2.20% | $46.67M |
| Great point partners | 317.22K | 1.95% | $10.30M |
| Highvista strategies | 173.80K | 1.75% | $6.67M |
| Deep track capital, lp | 3.35M | 1.58% | $108.82M |
| Nantahala capital management | 1.07M | 1.30% | $41.23M |
| Nextbio capital management lp | 69.55K | 1.14% | $2.67M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 1.11M | 0.00% | 1.11M |
| Fmr | 1.10M | 0.00% | 915.00K |
| Candriam s.c.a. | 284.23K | 0.05% | 284.23K |
| Boothbay fund management | 275.68K | 0.12% | 275.68K |
| Goldman sachs group | 576.46K | 0.00% | 212.66K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | 1.45M | 1.13% | -392.18K |
| Blackrock funding, inc. /de | 2.35M | 0.00% | -387.52K |
| Logos global management lp | 585.00K | 0.82% | -330.00K |
| Citadel advisors | 215.97K | 0.00% | -200.94K |
| Sixth street partners management company | - | - | -195.49K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard group | 1.11M | 0.00% | 1.11M | $24.77M |
| Candriam s.c.a. | 284.23K | 0.05% | 284.23K | $10.95M |
| Boothbay fund management | 275.68K | 0.12% | 275.68K | $8.95M |
| Janus henderson group | 65.43K | 0.00% | 65.43K | $1.61M |
| Numerai gp | 35.59K | 0.10% | 35.59K | $1.37M |
Sold Out
| Holder | Change |
|---|---|
| Rossby financial, lcc | -14.00 |
| Wpg advisers | -18.00 |
| Fifth third bancorp | -390.00 |
| Amalgamated bank | -605.00 |
| Federated hermes | -2.50K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 151 | 29.06% | 34,100,601 | 13.85% | 113 | 1.01% | 103 | 19.77% | 28 | 115.38% |
| Jun 30, 2026 | 116 | 50.65% | 29,937,149 | 6.12% | 106 | 0.85% | 85 | 66.67% | 13 | -7.14% |
| Mar 31, 2026 | 75 | 11.94% | 28,192,254 | 13.73% | 111 | 1.16% | 51 | 13.33% | 12 | - |
| Dec 31, 2025 | 19 | -64.15% | 6,707,654 | -66.37% | 26 | 0.43% | 17 | -67.92% | 2 | - |
| Sep 30, 2025 | 53 | - | 19,945,854 | - | 78 | - | 53 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 795.51K | 2.47% | 111.50K |
| Vanguard Total Stock Mkt Idx Inv | 672.00K | 2.34% | 72.90K |
| Vanguard Morn Total Stk Mkt Idx Investor | 672.00K | 2.34% | 72.90K |
| iShares Russell 2000 ETF | 565.93K | 1.75% | - |
| JPMorgan Small Cap Growth A | 459.00K | 1.42% | -52.56K |
| JPM Global Healthcare C acc USD | 381.69K | 1.18% | -76.38K |
| Vanguard Institutional Extnd Mkt Idx Tr | 282.60K | 0.99% | 3.80K |
| Jennison Health Sciences Equity | 231.15K | 0.81% | - |
| BlackRock Health Sciences Opps Inv A | 254.95K | 0.79% | -312.68K |
| Fidelity Small Cap Index | 245.44K | 0.76% | 526.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 30, 2026 | Deep Track Biotechnology Master Fund, Ltd. | - | Buy | $28.62 |
LBRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools